We are delighted by today's decision to allow patients with advanced prostate cancer to receive abiraterone on the NHS.
This drug was discovered at the Institute of Cancer Research and is the result of more than two decades of dedicated work by our scientists and and collaborators.
In clinical trials of men with advanced prostate cancer who have already tried chemotherapy, it has been shown to extend life by an average of four months and improve quality of life.
More top news
Leicester City manager Claudio Ranieri is confident of keeping his star names at the King Power Stadium next season.
Mourners have gathered for the funeral of army officer Capt David Seath who died after collapsing during the London Marathon.
ITV News can reveal the number of potential buyers for Tata's steel business in the UK is more than double the previously known total.